Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > J & J Granted BTD for treatment of NMIBC using TAR-200

<< Previous

Bullboard Posts

Next >>

Post by Infinityon Jan 04, 2024 6:08am

283 Views

Post# 35809994

J & J Granted BTD for treatment of NMIBC using TAR-200

We have some serious competition from J and J. Can anyone comment on the efficacy and safety of this treatment. Check out this link.

https://www.prnewswire.com/news-releases/johnson--johnsons-investigational-tar-200-granted-us-fda-breakthrough-therapy-designation-for-the-treatment-of-high-risk-non-muscle-invasive-bladder-cancer-302005075.html

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments